Dova Pharmaceuticals, Inc.

Swedish Orphan Biovitrum AB (Sobi) is pushing ahead with launching the thrombopoietin receptor agonist, Doptelet (avatrombopag, 20mg tablets), in the EU, part of its drive to transform into a hematol

Hopes of a substantial new indication for Swedish Orphan Biovitrum AB ’s oral thrombopoietin receptor agonist Doptelet (avatrombopag), in chemotherapy-induced thrombocytopenia (CIT), have faded after

Shares in Verona Pharma plc have rocketed after the UK respiratory disease specialist raised $200m in an oversubscribed private placement and subscription that will more than cover the costs of the

Verona Pharma PLC has highlighted the continuing unmet need for effective therapies for chronic obstructive pulmonary disease (COPD) and the potential role of its advanced clinical-stage product ensi